搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Clostridium difficile Hydroxyethylthiazole kinase (thiM) CSB-YP622097CAAQ
CSB-EP622097CAAQ
CSB-BP622097CAAQ
CSB-MP622097CAAQ
CSB-EP622097CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile UPF0145 protein CD630_17110 (CD630_17110) CSB-YP622098CAAQ
CSB-EP622098CAAQ
CSB-BP622098CAAQ
CSB-MP622098CAAQ
CSB-EP622098CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mannosyl-oligosaccharide 1,2-alpha-mannosidase C52E4.5 (C52E4.5), partial CSB-YP622099CXY
CSB-EP622099CXY
CSB-BP622099CXY
CSB-MP622099CXY
CSB-EP622099CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile Protein hfq (hfq) CSB-YP622100CAAQ
CSB-EP622100CAAQ
CSB-BP622100CAAQ
CSB-MP622100CAAQ
CSB-EP622100CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Surfeit locus protein 4 homolog (sft-4), partial CSB-YP622101CXY1
CSB-EP622101CXY1
CSB-BP622101CXY1
CSB-MP622101CXY1
CSB-EP622101CXY1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant UPF0359 membrane protein D1046.5 (D1046.5), partial CSB-YP622102CXY1
CSB-EP622102CXY1
CSB-BP622102CXY1
CSB-MP622102CXY1
CSB-EP622102CXY1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile Threonine--tRNA ligase (thrS), partial CSB-YP622103CAAQ
CSB-EP622103CAAQ
CSB-BP622103CAAQ
CSB-MP622103CAAQ
CSB-EP622103CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile 3-isopropylmalate dehydratase small subunit (leuD) CSB-YP622104CAAQ
CSB-EP622104CAAQ
CSB-BP622104CAAQ
CSB-MP622104CAAQ
CSB-EP622104CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile ATP-dependent helicase/nuclease subunit A (addA), partial CSB-YP622105CAAQ
CSB-EP622105CAAQ
CSB-BP622105CAAQ
CSB-MP622105CAAQ
CSB-EP622105CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile Methylglyoxal synthase (mgsA) CSB-YP622106CAAQ
CSB-EP622106CAAQ
CSB-BP622106CAAQ
CSB-MP622106CAAQ
CSB-EP622106CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile 50S ribosomal protein L32 (rpmF) CSB-YP622107CAAQ
CSB-EP622107CAAQ
CSB-BP622107CAAQ
CSB-MP622107CAAQ
CSB-EP622107CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile Elongation factor P (efp) CSB-YP622108CAAQ
CSB-EP622108CAAQ
CSB-BP622108CAAQ
CSB-MP622108CAAQ
CSB-EP622108CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile Translation initiation factor IF-2 (infB), partial CSB-YP622109CAAQ
CSB-EP622109CAAQ
CSB-BP622109CAAQ
CSB-MP622109CAAQ
CSB-EP622109CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile Polyribonucleotide nucleotidyltransferase (pnp), partial CSB-YP622110CAAQ
CSB-EP622110CAAQ
CSB-BP622110CAAQ
CSB-MP622110CAAQ
CSB-EP622110CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile Imidazole glycerol phosphate synthase subunit HisF (hisF) CSB-YP622111CAAQ
CSB-EP622111CAAQ
CSB-BP622111CAAQ
CSB-MP622111CAAQ
CSB-EP622111CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile Proline--tRNA ligase 1 (proS1), partial CSB-YP622112CAAQ
CSB-EP622112CAAQ
CSB-BP622112CAAQ
CSB-MP622112CAAQ
CSB-EP622112CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile DNA-directed RNA polymerase subunit beta' (rpoC), partial CSB-YP622113CAAQ
CSB-EP622113CAAQ
CSB-BP622113CAAQ
CSB-MP622113CAAQ
CSB-EP622113CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile 30S ribosomal protein S19 (rpsS) CSB-YP622114CAAQ
CSB-EP622114CAAQ
CSB-BP622114CAAQ
CSB-MP622114CAAQ
CSB-EP622114CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile 30S ribosomal protein S17 (rpsQ) CSB-YP622115CAAQ
CSB-EP622115CAAQ
CSB-BP622115CAAQ
CSB-MP622115CAAQ
CSB-EP622115CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile 50S ribosomal protein L15 (rplO) CSB-YP622116CAAQ
CSB-EP622116CAAQ
CSB-BP622116CAAQ
CSB-MP622116CAAQ
CSB-EP622116CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>